Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-10-06 Sale |
2022-10-07 4:05 pm |
Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director |
29,899 | $25.9 | $774,411 | 32,000 (Direct) |
View |
| 2022-09-30 Sale |
2022-10-04 5:49 pm |
Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director |
4,101 | $25.06 | $102,777 | 32,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-05 Option Award |
2025-02-07 4:37 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director |
25,000 | $0 | 90,000 (Direct) |
View |
| 2025-01-10 Option Award |
2025-01-13 5:30 pm |
N/A 2035-01-10 |
Eledon Pharmaceuticals Inc. | ELDN | Katkin Keith Director |
85,750 | $0 | 85,750 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-28 9:41 pm |
N/A 2031-05-22 |
Emergent BioSolutions Inc. | EBS | Katkin Keith Director |
43,178 | $0 | 85,620 (Direct) |
View |
| 2024-02-07 Option Award |
2024-02-09 4:04 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director |
17,000 | $0 | 65,000 (Direct) |
View |
| 2023-05-25 Option Award |
2023-05-30 7:05 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Katkin Keith Director |
33,847 | $0 | 42,442 (Direct) |
View |
| 2023-05-01 Option Award |
2023-05-02 6:45 pm |
N/A 2033-05-01 |
Eledon Pharmaceuticals Inc. | ELDN | Katkin Keith Director |
752,185 | $0 | 752,185 (Direct) |
View |
| 2023-02-02 Option Award |
2023-02-03 4:52 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director |
16,000 | $0 | 48,000 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-02 6:04 pm |
N/A 2033-02-01 |
Eledon Pharmaceuticals Inc. | ELDN | Katkin Keith Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-10-06 Exercise |
2022-10-07 4:05 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director |
20,782 | $7.88 | 32,000 (Direct) |
View |
| 2022-10-06 Exercise |
2022-10-07 4:05 pm |
N/A 2028-05-23 |
Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director |
29,899 | $0 | 32,000 (Direct) |
View |
| 2022-10-06 Exercise |
2022-10-07 4:05 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director |
9,117 | $8.93 | 32,000 (Direct) |
View |
| 2022-09-30 Exercise |
2022-10-04 5:49 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director |
3,218 | $7.88 | 32,000 (Direct) |
View |
| 2022-09-30 Exercise |
2022-10-04 5:49 pm |
N/A 2028-05-23 |
Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director |
4,101 | $0 | 32,000 (Direct) |
View |
| 2022-09-30 Exercise |
2022-10-04 5:49 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director |
883 | $8.93 | 32,000 (Direct) |
View |
| 2022-04-02 Option Award |
2022-04-05 4:22 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Katkin Keith Director |
8,595 | $0 | 8,595 (Direct) |
View |
Ownership |
2022-04-05 4:18 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Katkin Keith Director |
0 | $0 | 0 (Direct) |
View |
| 2022-02-02 Option Award |
2022-02-03 5:30 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director |
16,000 | $0 | 32,000 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-02 5:30 pm |
N/A 2032-02-01 |
Eledon Pharmaceuticals Inc. | ELDN | Katkin Keith Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-05-19 Option Award |
2021-05-21 8:57 pm |
N/A 2031-05-19 |
RIGEL PHARMACEUTICALS INC | RIGL | Katkin Keith Director |
55,000 | $0 | 55,000 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 4:18 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Katkin Keith Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2020-09-11 Option Award |
2020-09-15 8:10 pm |
N/A 2030-09-11 |
Novus Therapeutics Inc. | NVUS | Katkin Keith Director |
5,907 | $0 | 5,907 (Direct) |
View |
| 2020-05-15 Option Award |
2020-05-15 8:55 pm |
N/A 2030-05-15 |
RIGEL PHARMACEUTICALS INC | RIGL | Katkin Keith Director |
55,000 | $0 | 55,000 (Direct) |
View |